Teva- Pharmaceutical Industries Ltd
NYSE: TEVA
$17.51
-$0.25 (-1.4%)
Closing Price on September 20, 2024
TEVA Articles
Jon OggInvestors and traders are often on the hunt for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall Street...
Published:
ThinkstockTypically, specialty pharmaceutical companies either provide generic versions of former top-selling branded drugs or they may focus on drugs that target rare or hard to treat diseases as...
Published:
Last Updated:
Investors and traders are often on the hunt for fresh research ideas that will lead to higher income or more profits in this choppy stock and volatile market. 24/7 Wall St. reviews many fresh...
Published:
Last Updated:
The research team at UBS A.G. (NYSE: UBS) has released what Wall Street calls a Q-GARP list, which is simply “quality growth at a reasonable price.” Most investors will know this by GARP, growth...
Published:
Last Updated:
ThinkstockOver the past five weeks, the 10-year Treasury bond yield has increased by over one-half of one percent from 1.66% to 2.17%. The overall equity market has rallied 3.8% during this stretch...
Published:
Last Updated:
Investors and traders frequently search for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls to find great ideas to find value...
Published:
Last Updated:
ThinkstockTotal return is always the name of the game when it comes to investing success. Stocks that pay dividends on a regular basis help smooth out the rough spots when the market sells off or...
Published:
Last Updated:
ThinkstockThe world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating billions upon billions in annual sales in the United States alone. Some...
Published:
Last Updated:
As the stock market keeps hitting new highs, the spreads of high-yield bonds and junk bonds has been narrowing and narrowing. We even recently highlighted that these spreads were reaching what...
Published:
Last Updated:
Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Abaxis Inc. (NASDAQ: ABAX) cut to Underperform from Neutral. Activision...
Published:
U.S. equity markets opened flat this morning, largely due to a slew of data from Europe that essentially cancelled any good news with an equal dollop of bad. U.S. unemployment data came out before...
Published:
Last Updated:
U.S. equity markets opened lower this morning before bouncing into positive territory briefly and then turning south again. As happened yesterday, the focus was on Europe, where Italy’s oldest bank...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Wednesday. Align Technology Inc. (NASDAQ: ALGN) cut to Underperform as Bear of the...
Published:
Last Updated:
ThinkstockTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) is not getting any great warm welcome out of its 2012 investor meeting webcast. The company may soon find itself in a position where the...
Published:
Last Updated:
The stock market is mixed Tuesday, with the Dow Jones Industrial Average up 0.02%, the Nasdaq down 0.54% and the S&P 500 down 0.20%. Today’s winners include a pharmaceutical company entering...
Published:
Last Updated: